(2)
EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida.
CRYO will optimize cell recovery from the umbilical cord to supply umbilical cord cells under its previously announced CRADA agreement with the Biomedical Research Laboratory in Bethesda, Maryland, and for future IND application(s). The Agreement includes BTL marketing CRYO s products and services, and collaborative R&D efforts related to developing and improving protocols utilizing both CRYO s ATCell
American CryoStem and BioTherapeutic Labs Corp Enter into R&D, Collaboration and Marketing Agreement
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
American CryoStem and BioTherapeutic Labs Corp Enter into R&D, Collaboration and Marketing Agreement
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.